Isodiol International Inc ISOLF

RE:you wont hide this budda

[Runnerhunter]

TAKE 2 MINUTES TO READ IT

Runnerhunter wrote: Runnerhunter wrote: i always found the API thing kinda sketchy but i never really dig into it, and since this is looking like your last resort. I decided to give it a go.

I found a lot of thing pretty strange and i know you will deny all of it anyway but maybe some investors might be thinking otherwise.

first let me repost the news release about isodiol API certification.

April 26, 2018 – Vancouver, BC – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) (the “Company” or “Isodiol”), a global CBD innovator specializing in the development of pharmaceutical actives and health and wellness products, is pleased to announce that the Company’s wholly owned subsidiary BSPG Laboratories, LTD. has received government approval from United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA), in accordance with The Human Medicines Regulations 2012 (SI 2012/1916), for the manufacturing of the active substance Cannabidiol (CBD) under certificate number:  UK API 48727.

Notice here the use of the word THE SUBSTANCE and not THEIR. thats because MRHA approved cannabidiol. not only does the MRHA accept isodiol ones, they just accepted cannabidiol as a drug. 
https://yellowcard.mhra.gov.uk/iDAP/

Therefore meaning that the "API" certification is basically, nothing special and that would also mean why nobody else feel the need to put it in their product description.

ALSO, lets take a look at their API numbers : API 48727

if you go on google and type it, the first link goes to : https://ckan.publishing.service.gov.uk/data/metadata-api-docs

Thats right : NOTHING :ERROR 404, The resource could not be found.

United Kingdom’s Department of Health and is the regulatory agency that regulates medicines and medical devices. The MHRA is also a part of the European system of approval, where the MHRA or other national bodies can take on the verification work on behalf of all its members.  Further, the MHRA is recognised globally as an authority in its field and plays a leading role in protecting and improving public health and supports innovation through scientific research and development.

“This approval validates the consistent quality of our pure, natural CBD isolate and the patented manufacturing processes,” said CEO of Isodiol, Marcos Agramont.  “This event is a first in the industry and now enables Isodiol to focus on the development of CBD based drugs that will address a myriad of conditions that are affecting so many people around the world.  With this approval, we will now rapidly advance our pharmaceutical and drug development divisions.”

With the MHRA approval and because it meets all legal requirements under international law, the Company is now able to export the pure, natural CBD anywhere in the world, subject to pharmaceutical regulations. ( THAT IS A TOTAL LIE, YOU CANT EXPORT CBD ANYWHERE IN THE WORLD BECAUSE UK APPROVED IT)  This approval sets Isodiol apart from all other CBD companies globally as a secure and reliable supplier positioned to be able to serve this newly created demand for CBD drug development, approved pharmaceutical applications, research, clinical studies, and clinical trials.  Upon completion of the company’s new state-of-the-art manufacturing facility in Q1-2019, the Company’s production output capabilities will increase to approximately 20,000 kilos of CBD – API quality input material annually.

BTW why are you even promoting the word API when it mean : Active pharmaceutical ingredient, which have absulotly nothing to classified as "awsome"

Read more at https://stockhouse.com/companies/bullboard?symbol=c.isol&postid=29361652#SJGOHXPmObHUub2x.99